Miniatura

Fitxers

711662.pdf (1.01 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2021-05-12

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/184347

Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1093/jac/dkab069

Resum

Objectives: To investigate if the addition of cloxacillin to vancomycin enhances the activity of both monotherapies for treating MSSA and MRSA experimental endocarditis (EE) in rabbits. Methods: Vancomycin plus cloxacillin was compared with the respective monotherapies and daptomycin. In vitro time-kill studies were performed using standard (105 cfu) and high (108 cfu) inocula of five MRSA, one glycopeptide-intermediate (GISA) and five MSSA strains. One MSSA (MSSA-678) and one MRSA (MRSA-277) strain were selected to be used in the in vivo model. A human-like pharmacokinetics model was applied and the equivalents of cloxacillin 2 g/4 h IV and daptomycin 6 mg/kg/day IV were administered. To optimize vancomycin activity, dosage was adjusted to achieve an AUC/MIC ≥400. Results: Daptomycin sterilized significantly more vegetations than cloxacillin (13/13, 100% versus 9/15, 60%; P = 0.02) and showed a trend of better activity than vancomycin (10/14, 71%; P = 0.09) and vancomycin plus cloxacillin (10/14, 71%; P = 0.09) against MSSA-678. Addition of cloxacillin to vancomycin (13/15, 87%) was significantly more effective than vancomycin (8/16, 50%; P = 0.05) and showed similar activity to daptomycin (13/18, 72%; P = 0.6) against MRSA-277. In all treatment arms, the bacterial isolates recovered from vegetations were re-tested and showed the same daptomycin susceptibility as the original strains. Conclusions: Vancomycin plus cloxacillin proved synergistic and bactericidal activity against MRSA. Daptomycin was the most efficacious option against MSSA and similar to vancomycin plus cloxacillin against MRSA. In settings with high MRSA prevalence, vancomycin plus cloxacillin might be a good alternative for empirical therapy of S. aureus IE.

Matèries

Endocarditis, Staphylococcus aureus, Medicaments antibacterians, Epidemiologia

Matèries (anglès)

Endocarditis, Staphylococcus aureus, Antibacterial agents, Epidemiology

Citació

Col·leccions

Articles publicats en revistes (Genètica, Microbiologia i Estadística)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Citació

CASTAÑEDA, Ximena, GARCÍA DE LA MÀRIA, Cristina, GASCH, Oriol, PERICÀS, Juan m., SOY MUNER, Dolors, CAÑAS PACHECO, Maria alejandra, FALCES SALVADOR, Carles, GARCÍA GONZÁLEZ, Javier, HERNÁNDEZ-MENESES, Marta, VIDAL, Bàrbara, ALMELA, Manel, QUINTANA, Eduard, TOLOSANA, José m. (josé maría), FUSTER, David, LLOPIS, Jaume, DAHL, Anders, MORENO, Asuncion, MARCO, Francesc, MIRÓ MEDA, José m. (josé maría), Hospital Clínic Endocarditis Study Group. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis. _Journal of Antimicrobial Chemotherapy_. 2021. Vol. 76, núm. 6, pàgs. 1539-1546. [consulta: 20 de gener de 2026]. ISSN: 0305-7453. [Disponible a: https://hdl.handle.net/2445/184347]

Exportar metadades

JSON - METS

Compartir registre